We continuously expand our product pipeline—launching biosimilars in more markets around the globe while optimizing our manufacturing, supply, and commercial capabilities together with our partners.
- With a growing portfolio targeting areas of immunology, oncology, hematology, and endocrinology, we aim to provide access to biologics for more patients and healthcare providers around the world.
